Hologic acquires aesthetics company Cynosure for $1.65 billion

PelleFirm RF Body Treatment Systemfrom Cynosure

February 15, 2017
by Lauren Dubinsky , Senior Reporter
Hologic signed an agreement this week to acquire the medical aesthetics company Cynosure for approximately $1.65 billion. It will purchase all of Cynosure's outstanding shares for $66 each in cash.

Cynosure has a portfolio of over 20 products for noninvasive body contouring, hair removal, skin revitalization and women's health. The products are sold through direct sales and distributors in 130 plus countries.

The company recently launched the world's first FDA-cleared laser treatment for noninvasive body contouring, SculpSure. It also owns a carbon-dioxide laser for women's health called MonaLisa Touch.

Cynosure raked in $433.5 million in 2016 and reported top-line growth in 28 consecutive quarters. About 60 percent of the company's business comes from physicians outside the traditional areas of plastic surgery and dermatology, with a significant focus on OB/GYN applications.

The global medical aesthetics segment is worth more than $2 billion and is expected to grow at a low double-digit rate over the next few years. The aging population is taking an interest in aesthetics and physicians are looking to increase their cash-based procedures.

The aesthetics segment is not "subject to reimbursement risks, making it less cyclical," Margaret Kaczor, analyst at William Blair, told Reuters.

"Larger acquirers can access a fast growing, profitable market that is just in the first quarter of the game," she added.

On Monday, Botox manufacturer Allergan purchased Cynosure's competitor Zeltiq Aesthetics for around $2.48 billion.

The Hologic-Cynosure deal has an enterprise value of $1.44 billion net of cash. Hologic expects realized annualized cost synergies of about $25 million, three years after the close of the deal.

More Business Affairs

Dr. Martin T. Rothman

Three ways providers can improve patient satisfaction with online forms

Cerner head suggests negative reports about DoD contract may be 'fake news'

Strategies for rural health systems to remain competitive in today’s healthcare environment

Study finds ultrasound and mammo have highest no-show rates

FDA report opposes regulating third-party servicers

Change Healthcare, Adobe and Microsoft partner to address patient satisfaction

How SUD reprocessing delivers bigger value to health systems

Bronwen Taylor

Device recalls skyrocket by 126 percent in first quarter of 2018